$NHPAP
National Healthcare Properties, Inc. Stock $nhpap

$nhpap Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000162828024047225 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$88.94M	$85.69M
YoY Change		3.8%	2.67%
Cost Of Revenue
YoY Change
Gross Profit		$32.53M	$31.36M
YoY Change		3.74%	-2.8%
Gross Profit Margin		36.58%	36.6%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$111.4M	$86.43M
YoY Change		28.95%	-6.06%
Operating Profit		-$20.93M	-$912.0K
YoY Change		2194.52%	-89.08%
Interest Expense			$15.72M
YoY Change			18.34%
% of Operating Profit
Other Income/Expense, Net		-$19.84M	-$15.06M
YoY Change		31.79%	31.52%
Pretax Income		-$40.77M	-$15.97M
YoY Change		155.32%	-19.35%
Income Tax		$0.00	$157.0K
% Of Pretax Income
Net Earnings		-$40.77M	-$16.13M
YoY Change		152.83%	-18.87%
Net Earnings / Revenue		-45.84%	-18.82%
Basic Earnings Per Share		-$1.56	-$0.18
Diluted Earnings Per Share		-$1.56	-$0.18
COMMON SHARES
Basic Shares Outstanding	28.30M shares	113.2M shares	109.9M shares
Diluted Shares Outstanding		28.29M shares	111.4M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$32.86M	$51.04M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.998B	$2.172B
YoY Change	-8.04%	-0.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.289B	$1.232B
YoY Change	4.68%	7.06%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.132M	$1.098M
YoY Change	3.1%	5.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$702.6M	$934.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.998B	$2.172B
YoY Change	-8.04%	-0.07%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$40.77M	-$16.13M
YoY Change	152.83%	-18.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Revenues Revenues	266056000	usd
	us-gaap	Revenues Revenues	259145000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	54326000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	166557000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	161778000	usd
CY2024Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	8829000	usd
CY2024Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6391000	usd
CY2023Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6397000	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Address Line2 EntityAddressAddressLine2	27th Floor
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	415-6500
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	708306000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6314000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1504000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-364000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	979000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-86300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16358000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	5606000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	35261000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	16400000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	13998000	usd
	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	1709000	usd
	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	4580000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	82278000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	4803000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	58563000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49036000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4327000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	199160000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6960000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	240000000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	879000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	850000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	199000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	284000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	139000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	138000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21333000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47426000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6404000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14748000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76538000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84912000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91286000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32858000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	52054000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	40245000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84912000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91286000	usd
	us-gaap	Interest Paid Net InterestPaidNet	50798000	usd
	us-gaap	Interest Paid Net InterestPaidNet	46905000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	411000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	416000	usd
	us-gaap	Stock Issued1 StockIssued1	23695000	usd
	us-gaap	Stock Issued1 StockIssued1	67975000	usd
CY2024Q3	hct	Numberof Senior Housing Communities NumberofSeniorHousingCommunities	44	property
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28273944	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	dei	Entity Address Address Line1 EntityAddressAddressLine1	540 Madison Ave
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91316000	usd
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	5200000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	11498000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	19181000	usd
	dei	Entity Registrant Name EntityRegistrantName	National Healthcare Properties, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2024Q3	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2024Q3	us-gaap	Derivative Assets DerivativeAssets	17177000	usd
CY2024Q3	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2024Q3	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2024Q3	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	17177000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001561032
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	.25
CY2024Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	.25
CY2024Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	.25
CY2024Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	.25
CY2024Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	.25
CY2024Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
	us-gaap	Ancillary Fee Income Servicing Financial Asset Statement Of Income Or Comprehensive Income Extensible Enumeration AncillaryFeeIncomeServicingFinancialAssetStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#Revenues
CY2024Q3	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3888962
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Healthcare Trust, Inc.
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28296439	shares
CY2024Q3	us-gaap	Land Land	198124000	usd
CY2023Q4	us-gaap	Land Land	207987000	usd
CY2024Q3	hct	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	2051313000	usd
CY2023Q4	hct	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	2120352000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	290408000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	293295000	usd
CY2024Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2539845000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2621634000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	724985000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	681977000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1814860000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1939657000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32858000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46409000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	52054000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	44907000	usd
CY2024Q3	us-gaap	Derivative Assets DerivativeAssets	17177000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	28370000	usd
CY2024Q3	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	23056000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	26325000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7553000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7713000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	32874000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	35781000	usd
CY2024Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	17238000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	15997000	usd
CY2024Q3	us-gaap	Assets Assets	1997670000	usd
CY2023Q4	us-gaap	Assets Assets	2145159000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	816988000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	808995000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	363659000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	361026000	usd
CY2024Q3	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	6910000	usd
CY2023Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	8165000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	84472000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	48356000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8122000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8038000	usd
CY2024Q3	us-gaap	Deferred Rent Credit DeferredRentCredit	5717000	usd
CY2023Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	6500000	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3496000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3496000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	1289364000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1244576000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28296439	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28296439	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27886255	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27886255	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1132000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1115000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2533697000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2509303000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14301000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	23464000	usd
CY2024Q3	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1846558000	usd
CY2023Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1639804000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	702648000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	894154000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	5658000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	6429000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	708306000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	900583000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1997670000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2145159000	usd
CY2024Q3	us-gaap	Revenues Revenues	88940000	usd
CY2023Q3	us-gaap	Revenues Revenues	85686000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	56407000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	19153000	usd
CY2024Q3	hct	Termination Fees Related Party TerminationFeesRelatedParty	8409000	usd
CY2023Q3	hct	Termination Fees Related Party TerminationFeesRelatedParty	0	usd
	hct	Termination Fees Related Party TerminationFeesRelatedParty	106650000	usd
	hct	Termination Fees Related Party TerminationFeesRelatedParty	0	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5187000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	173000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5686000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	384000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5502000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4753000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16938000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14105000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20720000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20776000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63386000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	61520000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	111445000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	86425000	usd
	us-gaap	Operating Expenses OperatingExpenses	389896000	usd
	us-gaap	Operating Expenses OperatingExpenses	256940000	usd
CY2024Q3	hct	Operating Income Loss Before Gain Losson Saleof Real Estate Investments OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments	-22505000	usd
CY2023Q3	hct	Operating Income Loss Before Gain Losson Saleof Real Estate Investments OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments	-739000	usd
	hct	Operating Income Loss Before Gain Losson Saleof Real Estate Investments OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments	-123840000	usd
	hct	Operating Income Loss Before Gain Losson Saleof Real Estate Investments OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments	2205000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1579000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-173000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1354000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-364000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20926000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-912000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-122486000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1841000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18007000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	15720000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	52142000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	50208000	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	548000	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	258000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1077000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	576000	usd
CY2024Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-2384000	usd
CY2023Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	406000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	449000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	510000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19843000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15056000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-50616000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-49122000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40769000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15968000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-173102000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-47281000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	157000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	135000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	244000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-40769000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-16125000	usd
	us-gaap	Profit Loss ProfitLoss	-173237000	usd
	us-gaap	Profit Loss ProfitLoss	-47525000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-77000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-14000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-529000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-45000	usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	10350000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	10349000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44142000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19561000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-183058000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57829000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-10167000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	395000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-9163000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-1570000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-54309000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19166000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-192221000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-59399000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28291594	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28291594	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28279423	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28279423	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28283017	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28283017	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28273944	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28273944	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.56
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.56
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.05
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	900583000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	613000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.21
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	139000	usd
	us-gaap	Profit Loss ProfitLoss	-173237000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9163000	usd
	hct	Adjustmentsto Additional Paidin Capital Rebalancing Of Ownership Percentage AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage	0	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	762587000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	153000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.21
CY2024Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	47000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-40769000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10167000	usd
CY2024Q3	hct	Adjustmentsto Additional Paidin Capital Rebalancing Of Ownership Percentage AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage	0	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	708306000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	999190000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	689000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.68
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	138000	usd
	us-gaap	Profit Loss ProfitLoss	-47525000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1570000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	284000	usd
	hct	Adjustmentsto Additional Paidin Capital Rebalancing Of Ownership Percentage AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage	0	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	940581000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	959578000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	229000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.84
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-16125000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	395000	usd
CY2023Q3	hct	Adjustmentsto Additional Paidin Capital Rebalancing Of Ownership Percentage AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage	0	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	940581000	usd
	us-gaap	Profit Loss ProfitLoss	-173237000	usd
	us-gaap	Profit Loss ProfitLoss	-47525000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	63386000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61520000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2519000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5954000	usd
	hct	Amortization Accretion Of Terminated Swap Payment AmortizationAccretionOfTerminatedSwapPayment	-1218000	usd
	hct	Amortization Accretion Of Terminated Swap Payment AmortizationAccretionOfTerminatedSwapPayment	-2660000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	67000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	69000	usd
	hct	Accretion Of Below Market Lease Liabilities And Amortization Of Above Market Lease Assets Net AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet	-822000	usd
	hct	Accretion Of Below Market Lease Liabilities And Amortization Of Above Market Lease Assets Net AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet	-675000	usd
	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	914000	usd
	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	909000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	613000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	689000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1354000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-364000	usd
	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	5405000	usd
	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	3866000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	449000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	510000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	11498000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	360000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	938000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1338000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4180000	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2126000	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	5413000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7774000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	30267000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51041000	usd
	hct	Noncash Or Part Noncash Mortgages Issued With Acquisition Of Real Estate Investments NoncashOrPartNoncashMortgagesIssuedWithAcquisitionOfRealEstateInvestments	7500000	usd
	hct	Noncash Or Part Noncash Mortgages Issued With Acquisition Of Real Estate Investments NoncashOrPartNoncashMortgagesIssuedWithAcquisitionOfRealEstateInvestments	0	usd
	hct	Noncash Or Part Noncash Mortgage Notes Payable Secured In Connection With The Acquisition Of Real Estate NoncashOrPartNoncashMortgageNotesPayableSecuredInConnectionWithTheAcquisitionOfRealEstate	0	usd
	hct	Noncash Or Part Noncash Mortgage Notes Payable Secured In Connection With The Acquisition Of Real Estate NoncashOrPartNoncashMortgageNotesPayableSecuredInConnectionWithTheAcquisitionOfRealEstate	2663000	usd
	hct	Noncash Or Part Noncash Mortgage Notes Payable Repaid With Proceeds From Real Estate Sales NoncashOrPartNoncashMortgageNotesPayableRepaidWithProceedsFromRealEstateSales	0	usd
	hct	Noncash Or Part Noncash Mortgage Notes Payable Repaid With Proceeds From Real Estate Sales NoncashOrPartNoncashMortgageNotesPayableRepaidWithProceedsFromRealEstateSales	-2663000	usd
	hct	Noncash Or Part Noncash Proceeds From Real Estate Sales Used To Repay Amounts Outstanding Under Prior Credit Facility NoncashOrPartNoncashProceedsFromRealEstateSalesUsedToRepayAmountsOutstandingUnderPriorCreditFacility	0	usd
	hct	Noncash Or Part Noncash Proceeds From Real Estate Sales Used To Repay Amounts Outstanding Under Prior Credit Facility NoncashOrPartNoncashProceedsFromRealEstateSalesUsedToRepayAmountsOutstandingUnderPriorCreditFacility	5167000	usd
	hct	Noncash Or Part Noncash Amounts Outstanding Under Prior Credit Facility Repaid With Proceeds From Real Estate Sales NoncashOrPartNoncashAmountsOutstandingUnderPriorCreditFacilityRepaidWithProceedsFromRealEstateSales	0	usd
	hct	Noncash Or Part Noncash Amounts Outstanding Under Prior Credit Facility Repaid With Proceeds From Real Estate Sales NoncashOrPartNoncashAmountsOutstandingUnderPriorCreditFacilityRepaidWithProceedsFromRealEstateSales	-5167000	usd
CY2024Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	198	property
CY2024Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32	state
CY2024Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	8600000	sqft
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	hct	Number Of Independent Contractors NumberOfIndependentContractors	4	contractor
CY2024Q3	hct	Numberof Senior Housing Communities NumberofSeniorHousingCommunities	44	property
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	hct	Common Stock Par Or Stated Value Per Share After Reverse Stock Split CommonStockParOrStatedValuePerShareAfterReverseStockSplit	0.04
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, impairments, fair value measurements and income taxes, as applicable.</span></div>
	hct	Lease Remaining Lease Term LeaseRemainingLeaseTerm	P4Y3M18D
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	36985000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	104923000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	100211000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	90354000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	76190000	usd
CY2024Q3	hct	Lessor Operating Lease Paymenttobe Receivedafter Year Four LessorOperatingLeasePaymenttobeReceivedafterYearFour	375254000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	783917000	usd
CY2024Q3	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	100000	usd
	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	900000	usd
CY2023Q3	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	200000	usd
	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	900000	usd
CY2024Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	hct	Numberof Senior Housing Communities NumberofSeniorHousingCommunities	44	property
CY2023	hct	Number Of Intercompany Leases Modified NumberOfIntercompanyLeasesModified	26	lease
	hct	Deferred Tax Asset Valuation Allowance Percentage DeferredTaxAssetValuationAllowancePercentage	1
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8100000	usd
CY2024Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	198	property
CY2024Q3	hct	Real Estate Investment At Cost Relating To Notes Payable RealEstateInvestmentAtCostRelatingToNotesPayable	1300000000	usd
CY2024Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	28	encumberedproperty
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	363659000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	361026000	usd
CY2024Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0791
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0790
CY2024Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2500000000	usd
CY2024Q3	hct	Real Estate Investment At Cost Relating To Notes Payable RealEstateInvestmentAtCostRelatingToNotesPayable	1300000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1742000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	19039000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	735840000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	922000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	116989000	usd
CY2024Q3	hct	Long Term Debt Maturityafter Year Four LongTermDebtMaturityafterYearFour	317127000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1191659000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18007000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	15720000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	52142000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	50208000	usd
CY2024Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-2400000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	400000	usd
CY2023Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	400000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	500000	usd
	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	5400000	usd
	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	3900000	usd
CY2024Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	17177000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	28370000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	28370000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	28370000	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28296439	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27886255	shares
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	5200000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
	hct	Drip Periodof Noticeto Alter Agreement DRIPPeriodofNoticetoAlterAgreement	P10D
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	0	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.40
CY2020Q4	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.013492	shares
CY2021Q1	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.013492	shares
CY2021Q2	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014655	shares
CY2021Q3	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014655	shares
CY2021Q4	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014655	shares
CY2022Q1	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014655	shares
CY2022Q2	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014167	shares
CY2022Q3	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014167	shares
CY2022Q4	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014167	shares
CY2023Q1	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.014167	shares
CY2023Q2	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.015179	shares
CY2023Q3	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.015179	shares
CY2023Q4	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.015179	shares
CY2024Q1	hct	Common Stock Dividends Per Share Declared Shares CommonStockDividendsPerShareDeclaredShares	0.015179	shares
CY2024Q3	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	4907000	usd
CY2023Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	5734000	usd
CY2024Q3	hct	Noncontrolling Interests In Property Owning Subsidiaries NoncontrollingInterestsInPropertyOwningSubsidiaries	751000	usd
CY2023Q4	hct	Noncontrolling Interests In Property Owning Subsidiaries NoncontrollingInterestsInPropertyOwningSubsidiaries	695000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	5658000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	6429000	usd
CY2024Q3	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	-101000	usd
CY2023Q3	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	-16000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	-588000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	-71000	usd
CY2024Q3	hct	Noncontrolling Interest In Net Income Loss Property Owning Subsidiaries NoncontrollingInterestInNetIncomeLossPropertyOwningSubsidiaries	24000	usd
CY2023Q3	hct	Noncontrolling Interest In Net Income Loss Property Owning Subsidiaries NoncontrollingInterestInNetIncomeLossPropertyOwningSubsidiaries	2000	usd
	hct	Noncontrolling Interest In Net Income Loss Property Owning Subsidiaries NoncontrollingInterestInNetIncomeLossPropertyOwningSubsidiaries	59000	usd
	hct	Noncontrolling Interest In Net Income Loss Property Owning Subsidiaries NoncontrollingInterestInNetIncomeLossPropertyOwningSubsidiaries	26000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-77000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-14000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-529000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-45000	usd
CY2024Q3	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46000	usd
CY2023Q3	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	100000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	100000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44142000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19561000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-183058000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57829000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28291594	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28291594	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28279423	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28279423	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28283017	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28283017	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28273944	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.56
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.56
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.05
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	234026	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	251984	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	234026	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	257462	shares
CY2024Q3	hct	Common Share Equivalents Shares Outstanding CommonShareEquivalentsSharesOutstanding	359250	shares
CY2023Q3	hct	Common Share Equivalents Shares Outstanding CommonShareEquivalentsSharesOutstanding	359250	shares
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	us-gaap	Revenues Revenues	88940000	usd
CY2023Q3	us-gaap	Revenues Revenues	85686000	usd
	us-gaap	Revenues Revenues	266056000	usd
	us-gaap	Revenues Revenues	259145000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	32533000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	31360000	usd
	us-gaap	Gross Profit GrossProfit	99499000	usd
	us-gaap	Gross Profit GrossProfit	97367000	usd
CY2024Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	8829000	usd
CY2023Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	11498000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q3	us-gaap	Affiliate Costs AffiliateCosts	6391000	usd
CY2023Q3	us-gaap	Affiliate Costs AffiliateCosts	6397000	usd
	us-gaap	Affiliate Costs AffiliateCosts	19181000	usd
	us-gaap	Affiliate Costs AffiliateCosts	19153000	usd
CY2024Q3	hct	Termination Fees Related Party TerminationFeesRelatedParty	8409000	usd
CY2023Q3	hct	Termination Fees Related Party TerminationFeesRelatedParty	0	usd
	hct	Termination Fees Related Party TerminationFeesRelatedParty	106650000	usd
	hct	Termination Fees Related Party TerminationFeesRelatedParty	0	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5187000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	173000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5686000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	384000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5502000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4753000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16938000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14105000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20720000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20776000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63386000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	61520000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1579000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-173000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1354000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-364000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18007000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	15720000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	52142000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	50208000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	548000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	258000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	1077000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	576000	usd
CY2024Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-2384000	usd
CY2023Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	406000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	449000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	510000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	157000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	135000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	244000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-77000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-14000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-529000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-45000	usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	10350000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	10349000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44142000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19561000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-183058000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57829000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1814860000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1939657000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32858000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46409000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	52054000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	44907000	usd
CY2024Q3	us-gaap	Derivative Assets DerivativeAssets	17177000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	28370000	usd
CY2024Q3	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	23056000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	26325000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7553000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7713000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	32874000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	35781000	usd
CY2024Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	17238000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	15997000	usd
CY2024Q3	us-gaap	Assets Assets	1997670000	usd
CY2023Q4	us-gaap	Assets Assets	2145159000	usd
	hct	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	7	lease
	hct	Lessee Finance Lease Number Of Contracts LesseeFinanceLeaseNumberOfContracts	6	lease
	hct	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	7	lease
	hct	Lessee Operating Lease Renewal Term Excluded LesseeOperatingLeaseRenewalTermExcluded	P2Y
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7600000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8100000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P32Y4M24D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0735
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	163000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	23000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	653000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	93000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	649000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	95000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	617000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	97000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	619000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	100000	usd
CY2024Q3	hct	Lessee Operating Lease Liabilitytobe Paid Dueafter Year Four LesseeOperatingLeaseLiabilitytobePaidDueafterYearFour	21324000	usd
CY2024Q3	hct	Finance Lease Liabilitytobe Paid Dueafter Year Four FinanceLeaseLiabilitytobePaidDueafterYearFour	7115000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	24025000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7523000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15903000	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2693000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8122000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	4830000	usd
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-047225-index-headers.html	Edgar Link	pending
0001628280-24-047225-index.html	Edgar Link	pending
0001628280-24-047225.txt	Edgar Link	pending
0001628280-24-047225-xbrl.zip	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex3119302024.htm	Edgar Link	pending
ex3129302024.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
ex329302024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hct-20240930.htm	Edgar Link	pending
hct-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hct-20240930_cal.xml	Edgar Link	unprocessable
hct-20240930_def.xml	Edgar Link	unprocessable
hct-20240930_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
hct-20240930_lab.xml	Edgar Link	unprocessable
hct-20240930_pre.xml	Edgar Link	unprocessable
hct-20240930_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHPAP
National Healthcare Properties, Inc. Stock $nhpap

2024 Q4 Form 10-Q Financial Statement

#000162828024047225 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHPAP National Healthcare Properties, Inc. Stock $nhpap

2024 Q4 Form 10-Q Financial Statement

#000162828024047225 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHPAP
National Healthcare Properties, Inc. Stock $nhpap